Dr. Jonathan Abraham's lab at Harvard Medical School studies alphaviruses, which are mosquito-borne viruses that can lead to severe brain infections. The lab focuses on understanding the cellular receptors these viruses use to infect brain cells and exploring potential therapeutic approaches to prevent infections. By using advanced techniques like cryo-electron microscopy, the lab aims to visualize virus-receptor interactions and develop strategies to combat these dangerous pathogens.

The research lab led by Dr. Ethan Clark Garner at Harvard focuses on understanding the molecular mechanisms of bacterial cell division, specifically how proteins called FtsZ and FtsA deform the bacterial membrane to initiate this process. By studying these mechanisms, the lab aims to improve our understanding of antibiotic design and how to combat pathogenic bacteria more effectively. Their work combines in vivo experiments with in vitro studies to explore the physical properties and behaviors of these filaments at the cellular level.

Dr. Suzanne Walker's lab at Harvard Medical School focuses on understanding bacterial cell envelopes and their roles in antibiotic resistance. The team investigates how bacteria maintain their structural integrity and how this knowledge can aid in developing new antibiotics. By exploring the molecular mechanisms behind cell envelope biogenesis, the lab aims to identify new therapeutic targets to combat resistant bacterial infections.

Dr. Michael Starnbach's lab at Harvard Medical School focuses on understanding how the immune system, specifically CD8+ T cells, responds to infections caused by the bacterium Chlamydia trachomatis. The lab aims to uncover why these T cells are unable to form long-lasting memory after primary infection, which leads to repeated infections and potential infertility in affected individuals. Their research also explores new vaccine strategies to enhance immune response and protection against this significant public health issue.

John Joseph Mekalanos's lab at Harvard Medical School focuses on understanding the pathogenic mechanisms of Vibrio cholerae, the bacteria responsible for cholera. Their research explores how this pathogen interacts with the host immune system, commensal organisms, and viral agents. They also work on developing innovative vaccines and therapeutic approaches that could have far-reaching implications for public health and microbial immunology.

Dr. Nancy Kleckner's lab at Harvard University studies how chromosomes behave and organize themselves during important processes like cell division and reproduction. By examining both yeast and E. coli, the team explores the similarities between meiotic (sexual reproduction) and mitotic (cell division) chromosomes, looking for common patterns and mechanisms. Their work has implications for understanding infertility, cancer, and antibiotic resistance.

Dr. Naoshige Uchida's lab at Harvard University studies the neural circuits that control dopamine neuron activity, which is important for regulating behavior, motivation, and mood. Their research focuses on how different signals are processed in the brain's reward pathways and aims to uncover the mechanisms behind dopamine-related disorders like addiction and depression. By using advanced techniques, the lab investigates how neurons communicate and how learning influences these processes.

Dr. Sean R. Eddy's lab focuses on developing computational tools to analyze biological sequences and RNA structures. Their work is crucial for understanding evolutionary relationships among different life forms by leveraging large-scale genomic data. The lab's primary tools, HMMER and Infernal, help scientists find homologs of sequences more effectively, contributing to advancements in molecular biology and bioinformatics.

Dr. Florian Engert's lab at Harvard University studies how the brain and body interact, particularly focusing on zebrafish as a model organism. They aim to understand how animals perceive their environment and regulate their behaviors through neural circuits that are influenced by internal states like hunger and motivation. The lab investigates the genetic and neural mechanisms behind social behaviors, such as schooling and shoaling, using advanced imaging and modeling techniques.

Dr. Sarah Fortune's lab focuses on understanding how the bacterium Mycobacterium tuberculosis (Mtb) develops resilience to antibiotics, leading to treatment failures. The team investigates the genetic and molecular mechanisms that allow Mtb to survive antibiotic exposure and recover more effectively than usual. Ultimately, the lab aims to inform better treatment strategies for tuberculosis and enhance public health outcomes.

Dr. Wendy S. Garrett's lab at Harvard University focuses on understanding the role of the gut microbiome, particularly the bacterium Fusobacterium nucleatum, in colorectal cancer (CRC). The team investigates how specific bacterial activities contribute to CRC progression, response to therapy, and overall cancer susceptibility. By exploring the interactions between F. nucleatum and immune cells, the lab aims to uncover mechanisms that may apply to various cancers beyond CRC.

Dr. Rachelle Gaudet's lab at Harvard University studies membrane proteins, which are crucial for helping cells communicate and transport substances. By using techniques like X-ray crystallography and advanced microscopy, the lab investigates how these proteins work, particularly in bacteria. The research has important implications for drug development and understanding how bacteria adapt to their environments.

Dr. Christophe O. Benoist's lab focuses on understanding how T regulatory cells (Tregs) in the gut are maintained and shaped by the microbiome and food antigens. The lab investigates the role of Tregs in preventing inflammation and autoimmunity, particularly in the context of the IPEX syndrome, a condition related to faulty Treg function. Through a combination of advanced genetic techniques and single-cell analysis, the lab seeks to map the pathways that define Treg behavior and how they interact with their environment.

Dr. Sophie Helaine's research focuses on understanding how certain bacteria, like Salmonella, survive stressful conditions and become resistant to antibiotics. The lab studies specialized genes called Toxin-Antitoxin systems that help bacteria control their growth in response to threats from the immune system or antibiotics. By exploring how these systems are activated and how they function, the lab aims to uncover new strategies to combat antibiotic resistance and improve treatment for bacterial infections.

Ruaidhri Jackson's lab at Harvard Medical School focuses on uncovering the hidden complexities of the immune system's genome. The team is investigating non-coding RNAs and novel protein-coding mechanisms that play crucial roles in the inflammatory response. By using advanced techniques like ribosome profiling, they aim to redefine our understanding of gene function and discover new therapeutic targets for diseases related to immune response.

Dr. Dennis L. Kasper's lab at Harvard Medical School investigates how the gut's immune system, particularly a part called the complement system, protects against infections. They focus on how this system works locally in the gut rather than relying just on the blood. Recent findings show that a protein called C3, produced in the gut, plays a crucial role in fighting off pathogens such as bacteria that cause diarrhea. The lab aims to understand how the gut microbiome influences C3 levels and explore new therapeutic strategies for combating infectious diseases.

Dr. Vladimir Denic's lab at Harvard University focuses on understanding how proteins are formed and broken down in cells. The research explores a new chaperone system that helps build an important protein called eEF1A, which is essential for protein synthesis. The lab also investigates how cells manage damaged organelles through a process called selective autophagy, linking protein production and degradation. Together, this work aims to uncover the mechanisms that maintain protein balance and health in cells, which has implications for aging and diseases.

Dr. Manoj T. Duraisingh's lab focuses on understanding malaria, specifically how the malaria parasite Plasmodium vivax becomes resistant to antimalarial drugs and how it interacts with red blood cells. They conduct research to identify genetic factors that contribute to drug resistance and the ability of the parasite to invade different types of red blood cells, which is crucial for designing better treatments and control strategies against this disease.

Dr. Flaminia Catteruccia's lab at Harvard focuses on developing innovative strategies to combat malaria, specifically targeting the mosquitoes that spread the disease. The research involves creating new chemicals that can effectively kill the malaria-causing parasites within the mosquitoes while also addressing the problem of insecticide resistance. By optimizing these compounds to enhance their effectiveness and developing new textile products, the lab aims to contribute significantly to malaria prevention efforts.

Dr. Venkatesh N Murthy's lab at Harvard University focuses on understanding how animals make decisions based on sensory information, particularly in relation to smell. They study how the brain learns and maintains representations of odors, examines the neural circuits involved in tracking these scents, and investigates how experiences affect learning in the brain. Their work combines behavioral experiments with advanced imaging techniques to uncover the neural mechanisms that underpin decision-making and sensory processing.